The veteran pharmaceutical executive takes charge of after the failed launch of Biogen’s once-promising Alzheimer’s disease drug Aduhelm. Source link Source link
Read MoreTag: GSK.LN
Rival drugmakers are seeking to upend Pfizer Inc.’s dominance of the $7 billion worldwide market for pneumonia vaccines, launching what is shaping up to be one of the industry’s fiercest battles. Merck & Co. has already introduced a new competitor to Pfizer’s Prevnar vaccine franchise, while GSK PLC and Vaxcyte Inc. are among companies developing […]
Read More